From: Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder
Patient characteristics a | N (%) or mean (±SD) b | |||
---|---|---|---|---|
SCORPIO (n = 1906) | ARIES (n = 1270) | CAPRICORN (n = 1251) | Pooled trials (n = 4427) | |
Age | 59.1 (±12.4) | 60.2 (±13.4) | 59.1 (±13.0) | 59.4 (±12.9) |
Female | 1372 (72.0%) | 950 (74.8%) | 857 (68.5%) | 3179 (71.8%) |
BMI | 27.8 (±4.9) | 30.2 (±7.0) | 29.4 (±6.4) | 28.9 (±6.1) |
Geographical region | ||||
Western Europe | 1906 (54.2%) | 0 (0.0%) | 359 (28.7%) | 1392 (31.4%) |
Eastern Europe | 873 (45.8%) | 0 (0.0%) | 222 (17.8%) | 1095 (24.7%) |
USA | 0 (0.0%) | 127 (10.0%) | 584 (46.7%) | 1727 (39.0%) |
Canada | 0 (0.0%) | 1143 (90.0%) | 86 (6.9%) | 213 (4.8%) |
Previously treated with antimuscarinics | 946 (49.6%) | 714 (56.2%) | 642 (51.3%) | 2302 (52.0%) |
Baseline mean number of micturitions per 24 h | 11.6 (±2.9) | 11.7 (±3.4) | 11.6 (±3.1) | 11.6 (±3.1) |
Baseline mean number of incontinence episodes per 24 h | 1.7 (±2.4) | 2.1 (±2.7) | 2.3 (±2.3) | 1.8 (±2.5) |